Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer

Stopped Drug Manufacturer withdrew support for studies not in metastatic breast cancer

Conditions

• Stages II-III Breast Cancer

Interventions

• DRUG: Nanoparticle Albumin Bound Paclitaxel
• DRUG: doxorubicin
• DRUG: cyclophosphamide

Sponsor

University of Utah

Collaborators

• [object Object]